Xiang Guo Selected Research

pyroligneous acid

1/2021

Influence of Pyroligneous Acid on Fermentation Parameters, CO2 Production and Bacterial Communities of Rice Straw and Stylo Silage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang Guo Research Topics

Disease

120	Nasopharyngeal Carcinoma 01/2022 - 01/2002
59	Neoplasms (Cancer) 06/2022 - 01/2002
45	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2002
9	Rheumatoid Arthritis 12/2021 - 06/2017
7	Necrosis 04/2022 - 06/2009
6	Inflammation (Inflammations) 06/2022 - 11/2011
5	Carcinogenesis 01/2020 - 01/2006
4	Ulcerative Colitis 04/2022 - 11/2021
4	Hypoxia (Hypoxemia) 01/2022 - 04/2006
4	Mucositis 01/2022 - 01/2017
4	Moyamoya Disease (Moya-Moya Disease) 11/2021 - 01/2016
3	Human Influenza (Influenza) 11/2022 - 03/2020
3	COVID-19 11/2022 - 10/2021
3	Pneumonia (Pneumonitis) 04/2022 - 01/2021
3	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 08/2019
3	Infections 10/2021 - 09/2014
3	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2021 - 04/2004
3	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2004
3	Neutropenia 01/2021 - 09/2013
3	Rib Fractures (Rib Fracture) 07/2020 - 01/2019
3	Body Weight (Weight, Body) 01/2020 - 07/2014
3	Type 2 Diabetes Mellitus (MODY) 07/2014 - 11/2012
2	Anemia 01/2022 - 01/2015
2	Bone Fractures (Bone Fracture) 01/2022 - 04/2014
2	Nausea 01/2022 - 01/2018
2	Vomiting 01/2022 - 01/2018
2	Weight Loss (Weight Reduction) 01/2021 - 01/2017
2	Pneumococcal Infections 01/2021 - 01/2021
2	Hemorrhage 11/2020 - 11/2019
2	Pain (Aches) 07/2020 - 01/2019
2	Flail Chest 07/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 04/2020 - 02/2015
2	Emphysema 11/2019 - 08/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2019 - 08/2015
2	Poisoning 12/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

27	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2002
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
14	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2004
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2007
7	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 02/2010
6	Pharmaceutical PreparationsIBA 12/2021 - 02/2010
6	Monoclonal AntibodiesIBA 01/2021 - 01/2014
6	PlatinumIBA 01/2021 - 02/2010
6	Indicators and Reagents (Reagents)IBA 01/2017 - 10/2004
5	VaccinesIBA 11/2022 - 01/2021
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2019 - 08/2015
5	C-Reactive ProteinIBA 07/2018 - 01/2013
5	Immunoglobulin A (IgA)IBA 11/2017 - 03/2003
4	tofacitinibIBA 04/2022 - 11/2021
4	Biological ProductsIBA 01/2022 - 11/2008
4	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 12/2013
4	Hemoglobins (Hemoglobin)IBA 06/2020 - 06/2005
4	LipidsIBA 01/2019 - 07/2014
4	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 02/2010
4	Endothelin A ReceptorIBA 08/2013 - 05/2005
3	ImmunosorbentsIBA 06/2022 - 07/2012
3	EnzymesIBA 06/2022 - 07/2012
3	CytokinesIBA 06/2022 - 08/2015
3	Janus Kinase InhibitorsIBA 01/2022 - 11/2021
3	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2004
3	Cytidine Triphosphate (CTP)IBA 11/2021 - 01/2016
3	Complement System Proteins (Complement)IBA 01/2021 - 02/2014
3	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2021 - 03/2020
3	3-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA 01/2021 - 01/2013
3	Therapeutic UsesIBA 01/2021 - 03/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2004
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 08/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 12/2013
3	mavrilimumabIBA 01/2018 - 06/2017
3	Messenger RNA (mRNA)IBA 01/2017 - 12/2002
3	raf KinasesIBA 09/2016 - 03/2013
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 03/2020
2	MXeneIBA 03/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 04/2020
2	Durapatite (Hydroxylapatite)IBA 01/2022 - 04/2014
2	Biocompatible Materials (Biomaterials)IBA 11/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 03/2016
2	lobaplatinIBA 01/2021 - 01/2017
2	durvalumabIBA 01/2021 - 01/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 09/2015
2	AntigensIBA 01/2021 - 02/2013
2	HDL CholesterolIBA 01/2019 - 07/2014
2	TitaniumIBA 12/2018 - 11/2011

Therapy/Procedure

47	Radiotherapy 01/2022 - 03/2003
32	Chemoradiotherapy 01/2022 - 03/2008
25	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
19	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 12/2012
18	Induction Chemotherapy 01/2022 - 10/2009
12	Therapeutics 01/2022 - 07/2008
5	Neoadjuvant Therapy 01/2019 - 09/2013
5	Re-Irradiation 10/2016 - 07/2007
3	Immunotherapy 03/2022 - 02/2015
3	Aftercare (After-Treatment) 11/2021 - 03/2003
3	Conservative Treatment 07/2020 - 10/2013
2	Phototherapy (Light Therapy) 03/2022 - 01/2021
2	TP protocol 01/2022 - 01/2022
2	Length of Stay 07/2020 - 01/2019
2	Minimally Invasive Surgical Procedures 07/2020 - 11/2019
2	Neck Dissection (Radical Neck Dissection) 01/2020 - 01/2019
2	Thoracotomy 08/2019 - 09/2014